The Health Secretary will set out a 10-year plan including proposals to bring down the cost of drugs such as Wegovy and ...

Hong Kong – Novo Nordisk and Eli Lilly & Co, the pharmaceutical giants dominating the ... alternative versions of semaglutide – the active ingredient in Novo’s Wegovy – launch after semaglutide’s ...

Novo Nordisk A/S and Eli Lilly & Co, the pharmaceutical giants dominating ... product revenue of 704 million Danish kroner ($110 million) in China to Wegovy’s local launch. Lilly has said it plans to ...

Wall Street’s major averages closed Friday's trading session higher, as both the S&P 500 (SP500) and Nasdaq Composite ...

With the notable exceptions of Novo Nordisk A/S (NYSE: NVO) and Eli Lilly & Co. (NYSE: LLY), biotechnology stocks had a rough ...

In what she calls the "wild west" of obesity medicines, Missouri-based Amy Spencer is a pioneer.